CHC Healthcare Group (TPE:4164)

Market Cap	8.36B
Revenue (ttm)	3.95B
Net Income (ttm)	174.52M
Shares Out	170.68M
EPS (ttm)	1.01
PE Ratio	48.48
Forward PE	n/a
Dividend	1.51 (3.08%)
Ex-Dividend Date	Jun 26, 2025

Volume	5,709,344
Average Volume	2,173,620
Open	48.65
Previous Close	49.00
Day's Range	48.65 - 51.30
52-Week Range	35.50 - 60.40
Beta	0.31
RSI	65.71
Earnings Date	Aug 13, 2025

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally. The company is also involved in the sale, leasing, installing, and repairing of medical instruments. In addition, it engages in the sale of ophthalmic equipment; irradiation business; sale of drug and health supplements; consulting, elderly residence, and senior fitness services; Long-term care services; and leasing of veterinary medical instruments. CHC Healthcare Group was founded in 1977 a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1977
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2024, CHC Healthcare Group's revenue was 3.60 billion, a decrease of -7.13% compared to the previous year's 3.88 billion. Earnings were 168.38 million, a decrease of -59.80%.